135 related articles for article (PubMed ID: 32366552)
1. C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer: A Systematic Review and Meta-Analysis.
Liao DW; Hu X; Wang Y; Yang ZQ; Li X
Ann Clin Lab Sci; 2020 Mar; 50(2):161-171. PubMed ID: 32366552
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels could be a prognosis predictor of prostate cancer: A meta-analysis.
Zhou K; Li C; Chen T; Zhang X; Ma B
Front Endocrinol (Lausanne); 2023; 14():1111277. PubMed ID: 36817592
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis.
Hu Q; Gou Y; Sun C; Ding W; Xu K; Gu B; Xia G; Ding Q
Urol Oncol; 2014 Jan; 32(1):50.e1-8. PubMed ID: 24239465
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
7. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis.
Cao J; Zhu X; Zhao X; Li XF; Xu R
PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.
Chen Y; Cong R; Ji C; Ruan W
Cancer Med; 2020 Dec; 9(24):9541-9553. PubMed ID: 33201589
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of C-reactive protein in esophageal cancer: a meta-analysis.
Zheng TL; Cao K; Liang C; Zhang K; Guo HZ; Li DP; Zhao S
Asian Pac J Cancer Prev; 2014; 15(19):8075-81. PubMed ID: 25338987
[TBL] [Abstract][Full Text] [Related]
11. The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis.
Han CL; Meng GX; Ding ZN; Dong ZR; Chen ZQ; Hong JG; Yan LJ; Liu H; Tian BW; Yang LS; Xue JS; Li T
Front Immunol; 2022; 13():827788. PubMed ID: 35211122
[TBL] [Abstract][Full Text] [Related]
12. Pooled Analysis of C-Reactive Protein Levels and Mortality in Prostate Cancer Patients.
Graff JN; Beer TM; Liu B; Sonpavde G; Taioli E
Clin Genitourin Cancer; 2015 Aug; 13(4):e217-e221. PubMed ID: 25735198
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Lactate Dehydrogenase in Metastatic Prostate Cancer: A Systematic Review and Meta-analysis.
Mori K; Kimura S; Parizi MK; Enikeev DV; Glybochko PV; Seebacher V; Fajkovic H; Mostafaei H; Lysenko I; Janisch F; Egawa S; Shariat SF
Clin Genitourin Cancer; 2019 Dec; 17(6):409-418. PubMed ID: 31558410
[TBL] [Abstract][Full Text] [Related]
14. Preoperative C-reactive protein as a prognostic predictor for upper tract urothelial carcinoma: A systematic review and meta-analysis.
Luo Y; Fu SJ; She DL; Xiong HU; Yang LI
Mol Clin Oncol; 2015 Jul; 3(4):924-928. PubMed ID: 26171208
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of C-reactive protein in prognosis evaluation of prostate cancer: a systematic review and meta-analysis.
Du J; Lan J; Xiong J; Yang H; Xu X; Tang C; Huang G; Ying Q; Mu J; Hu Q
Transl Cancer Res; 2021 Oct; 10(10):4432-4439. PubMed ID: 35116300
[TBL] [Abstract][Full Text] [Related]
16. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
Wang X; Liu S; Zhao X; Fang E; Zhao X
PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the C-reactive protein to albumin ratio in esophageal cancer: A systematic review and meta-analysis.
Wang Y; Hu X; Huang Y; Xu WY; Wu YM; Li PF; Che GW
Kaohsiung J Med Sci; 2020 Jan; 36(1):54-61. PubMed ID: 31512813
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
19. The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis.
He K; Hu H; Ye S; Wang H; Cui R; Yi L
Sci Rep; 2019 Feb; 9(1):2218. PubMed ID: 30778081
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.
Cattrini C; Rubagotti A; Nuzzo PV; Zinoli L; Salvi S; Boccardo S; Perachino M; Cerbone L; Vallome G; Latocca MM; Zanardi E; Boccardo F
Clin Genitourin Cancer; 2018 Dec; 16(6):e1257-e1265. PubMed ID: 30170989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]